More articles from Volume 46, Issue 3, 2017
Randomization techniques in protocols for cluster randomized trials
Systematic review of factor validity of psychiatric scales in longitudinal studies
Comparison of clinical, biochemical and morphological parameters in patients with chronic hepatitis B
Impact of ocular comorbidities on visual function and quality of life in cataract and pseudophakic patients
Effects of different doses of zinc gluconate on antioxidative activity of metformin and glibenclamide on experimentally induced diabetes in rabbits
Effects of different doses of zinc gluconate on antioxidative activity of metformin and glibenclamide on experimentally induced diabetes in rabbits
,
Zorica Stanojevic-Ristic
,
Julijana Rasic
,
Snezana Stevic
,
Dragana Valjarevic
Momcilo Stanic
Abstract
Keywords
References
1.
Kostić N, Čaparević Z, Ilić S. Antioksidantni status bolesnika sa dijabetesom tip 2 u odnosu na mikrovaskularne komplikacije. Srpski Arhiv za celokupno lekarstvo. 2007;(3–4):143–6.
2.
Đorđević G, Đurić S, Apostolski S, Đorđević V, Živković M. Totalni antioksidativni kapacitet plazme kod bolesnika sa dijebetesom melitusom tip 2 i distalnom simetričnom polineuropatijom. Vojnosanitetski pregled. 2008;(9):663–9.
3.
Pavlović D, Đorđević V, Kostić G. Ćelijska signalna transdukcija -modulacija slobodnim radikalima. Jugoslov Med Biohem. 2002;69–84.
4.
Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes. 2002;159–67.
5.
Obi C, B, Okoye C, Okpashi T, V. Nonye Igwe C, Olisah Alumanah E. Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats. J Diabetes Res. 2016;1635361.
6.
Quaterman J, Mills C, Humphries W. The reduced secretion of, and sensitivity to insulin in zinc-deficient rats. Biochem Biophys Res Commun. 1966;(3):354–8.
7.
Kinlaw W, Levine A, Morley J. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med. 1983;273–7.
8.
Cunningham J, Fu A, Mearkle P, Brown R. Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation. Metabolism. 1994;1558–62.
9.
Đukić M. Oksidativni stres, slobodni radikali, prooksidansi, antioksidansi. Mono i Manjana. 2008;
10.
Foster M, Samman S. Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid Redox Signal. 2010;1549–73.
11.
Maret W, Sandstead H. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006;3–18.
12.
Peretz A, Papadopoulos T, Willems D. Zinc supplementation increases bone alkaline phosphatase in healthy men. J Trace Elem Med Biol. 2001;175–8.
13.
Al-Maroof Ra, Ss AS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J. 2006;344–50.
14.
Parham M, Amini M, Aminorroaya A, Heidarian E. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud. 2008;102–9.
15.
Shukla R, Anand K, Prabhu K, Murthy P. Hypolipidemic effect of water extract of Ficus bengalensis in alloxan induced diabetes mellitus in rabbits. Ind J Clin Biochem. 1995;(2):122–4.
16.
Babu B, Moorti R, Pugazhenthi S, Prabhu K, Murthy P. Alloxan recovered rabbits as animal model for screening for hypoglycemic activity of compounds. Indian Journal of Biochemistry & Biophysics. 1988;(6):714–8.
17.
Goldstein S, Michel C, Boors A, Saran M, Czapsky G. A critical reevaluation of some assay methods for superoxide dismutase activity. Free Radical Biol Med. 1988;295–303.
18.
Miller N, Rice-Evans C, Davies M, Gopinathan V, Milner A. Clinical Science. 1993;407–12.
19.
Greilling H, Gressner A. Lehrbuch der Klinischen Chelie und Pathobiochemie. 1995;
20.
Opara E, Abdel-Rahman E, Soliman S, Kamel W, Souka S, Lowe J. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism. 1999;(11):1414–7.
21.
Pavlovic D, Kocic R, Kocic G, Jevtovic T, Radenkovic S, Mikic D, et al. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabtes. Diabetes Obes Metab. 2000;251–6.
22.
Paik H, Joung H, Lee J, Lee H, King J, Keen C. Serum Extracellular Superoxide Dismutase Activity as an Indicator of Zinc Status in Humans Biological Trace Element Research. 1999;45–57.
23.
Duzguner V, Kaya S. Effect of zinc on the lipid peroxidation and the antioxidant defense system of the alloxan-induced diabetic rabbit. Free radical Biology and Medicine. 2007;1481–6.
24.
Cousins R. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev. 1985;238–309.
25.
Sasari M, Nyakas C. Time dependent changes in oxidative metabolism during chronic diabetes in rats. Acta Biologica Szegediensis. 2003;153–8.
26.
Majithiya J, Balaraman R. Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocininduced diabetic rats treated with curcumin. J Cardiovasc Pharmacol. 2005;(5):697–705.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
